Vireo Growth Inc. (CSE:VREO)
0.6300
-0.0300 (-4.55%)
Mar 31, 2025, 4:00 PM EST
Vireo Growth Company Description
Vireo Growth Inc. operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, and New York.
It sells cannabis products through a network of retail dispensaries and distributors. The company was formerly known as Goodness Growth Holdings, Inc. and changed its name to Vireo Growth Inc. in July 2024.
Vireo Growth Inc. was incorporated in 2004 and is headquartered in Minneapolis, Minnesota.
Vireo Growth Inc.
Country | Canada |
Founded | 2004 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 520 |
CEO | John Mazarakis |
Contact Details
Address: 207 South 9th Street Minneapolis, British Columbia 55402 United States | |
Phone | 612 999 1606 |
Website | vireogrowth.com |
Stock Details
Ticker Symbol | VREO |
Exchange | Canadian Securities Exchange |
Fiscal Year | January - December |
Reporting Currency | USD |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Dr. Kyle E. Kingsley | Founder, Chairman and Chief Executive Officer |
John A. Heller | Chief Financial Officer |
Christian Gonzalez Ocasio | Chief Operating Officer |
Amber H. Shimpa | Chief Administrative Officer and Director |
Sam Gibbons | Vice President of Investor Relations |
J. Michael Schroeder | Chief Compliance Officer, Company Secretary and General Counsel |
Dr. Stephen M. Dahmer M.D. | Chief Medical Officer |
Patrick Peters | Executive Vice President of Retail |